Avalon Pharma EGM authorizes board to pay interim dividends for 2024

01/07/2024 Argaam
Logo ofMiddle East Pharmaceutical Industries Co. (Avalon Pharma)

Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma)

Middle East Pharmaceutical Industries Co. (Avalon Pharma) shareholders authorized the board of directors to distribute interim dividends to shareholders semi-annually or quarterly for 2024.

 

The decision was taken during the extraordinary general meeting (EGM) held on June 30, the company said in a statement on Tadawul.

 

In addition, shareholders approved to discharge board members from liability for the year ended on Dec. 31, 2023, the statement added.

 

For more news on listed companies

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.